Showing results (671-680 of 993) with videos related to

Sort By:
Pageof 100
International Journal of Molecular Sciences|July 24, 2021
Evidence-Based Second-Line Treatment in RAS Wild-Type/Mutated Metastatic Colorectal Cancer in the Precision Medicine EraGuido Giordano, Pietro Parcesepe, Giuseppina Bruno, et al.
The Journal of Endocrinology|April 17, 2003
Fibroblast growth factor 7, secreted by breast fibroblasts, is an interleukin-1beta-induced paracrine growth factor for human breast cellsC Palmieri, D Roberts-Clark, A Assadi-Sabet, et al.
Clinical & Experimental Metastasis|August 24, 2018
Black race and distant recurrence after neoadjuvant or adjuvant chemotherapy in breast cancerJessica M Pastoriza, George S Karagiannis, Juan Lin, et al.
The New England Journal of Medicine|April 19, 2008
Weekly paclitaxel in the adjuvant treatment of breast cancerJoseph A Sparano, Molin Wang, Silvana Martino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2016
Cetuximab Plus Chemoradiotherapy for HIV-Associated Anal Carcinoma: A Phase II AIDS Malignancy Consortium TrialJoseph A Sparano, Jeannette Y Lee, Joel Palefsky, et al.
NPJ Breast Cancer|February 23, 2024
Lumpectomy without radiation for ductal carcinoma in situ of the breast: 20-year results from the ECOG-ACRIN E5194 studyJean L Wright, Robert Gray, Habib Rahbar, et al.
Breast Cancer Research and Treatment|December 22, 2009
Recommendations for research priorities in breast cancer by the coalition of cancer cooperative groups scientific leadership council: imaging and local therapyJoseph A Sparano, Etta D Pisano, Julia R White, et al.
Medical Education|August 19, 2020
Examiners' decision-making processes in observation-based clinical examinationsBunmi S Malau-Aduli, Richard B Hays, Karen D'Souza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1991
A phase II study of high-dose continuous infusion interleukin-2 with lymphokine-activated killer cells in patients with metastatic melanomaJ P Dutcher, E R Gaynor, D H Boldt, et al.
Pageof 100